Vitamin d3 nanostructured lipid carriers

Abstract

The present invention relates to nanostructured lipid carriers (NLC) comprising vitamin D3 compounds, pharmaceutical compositions comprising the NLCs, and to their use in the treatment or prevention of diseases related to vitamin D deficiency, such as vitamin D deficiency, demineralization such as hypocalcemia and hypophosphatemia, renal osteodystrophy, rickets, osteoporosis, osteopenia, osteoarthritis, osteoarthrosis, osteomalacia, hypoparathyroidism, and inflammatory bowel disease, and to their process of manufacture.

Images